Jan Marsal

13PUBLICATIONS
36CO-AUTHORS
Rheumatology and arthritisPredictive and prognostic markersFoetal development and medicineDisease surveillanceApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 22, 2025
Gut inflammation is associated with structural spinal damage in axial spondyloarthritis - results from the observational SPARTAKUS cohort.

Johan Karlsson Wallman, Elisabeth Mogard, Jonas Sagard

|Feb 13, 2025
Inflammatory Bowel Disease, Periconceptional Disease Activity, and Risk of Major Congenital Anomalies: A Nationwide Cohort Study.

Karl Mårild, Jonas Söderling, Olof Stephansson

|Jun 05, 2023
Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study.

Isabella Visuri, Carl Eriksson, Sara Karlqvist

|Apr 26, 2022
Real-world data on switching from intravenous to subcutaneous vedolizumab treatment in patients with inflammatory bowel disease.

Viktoria Bergqvist, Johanna Holmgren, Daniel Klintman

|Jul 19, 2021
Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study.

Carl Eriksson, Sara Rundquist, Vyron Lykiardopoulos

Pageof 3